These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 34567847)
21. Gene Expression Characteristics of Tumor and Adjacent Non-Tumor Tissues of Pancreatic Ductal Adenocarcinoma (PDAC) In-Silico. Güven E Iran J Biotechnol; 2022 Jan; 20(1):e3092. PubMed ID: 35891953 [TBL] [Abstract][Full Text] [Related]
22. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients. Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z J Oncol; 2021; 2021():4986227. PubMed ID: 34987579 [TBL] [Abstract][Full Text] [Related]
23. Identification of New Potential Targets for Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatic Analysis. Li R; Yang T; Ren KE; Li J; Nagakawa Y; Zeng Y; Natsuyama Y; Yi SQ Anticancer Res; 2024 Oct; 44(10):4233-4250. PubMed ID: 39348994 [TBL] [Abstract][Full Text] [Related]
24. Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma. Gu Y; Feng Q; Liu H; Zhou Q; Hu A; Yamaguchi T; Xia S; Kobayashi H Heliyon; 2019 Aug; 5(8):e02378. PubMed ID: 31489384 [TBL] [Abstract][Full Text] [Related]
25. Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression. Pan Z; Li L; Fang Q; Zhang Y; Hu X; Qian Y; Huang P Cancer Cell Int; 2018; 18():214. PubMed ID: 30598639 [TBL] [Abstract][Full Text] [Related]
26. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma. Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415 [TBL] [Abstract][Full Text] [Related]
27. Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis. Zhou Z; Cheng Y; Jiang Y; Liu S; Zhang M; Liu J; Zhao Q Int J Biol Sci; 2018; 14(2):124-136. PubMed ID: 29483831 [TBL] [Abstract][Full Text] [Related]
28. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data. Li N; Zhao X; You S Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213 [TBL] [Abstract][Full Text] [Related]
29. Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis. Ding W; Wang Y; Ma Y; Lin L; Li M Dis Markers; 2022; 2022():3839480. PubMed ID: 36061357 [TBL] [Abstract][Full Text] [Related]
31. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape. Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833 [TBL] [Abstract][Full Text] [Related]
32. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods. Li C; Zeng X; Yu H; Gu Y; Zhang W World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899 [TBL] [Abstract][Full Text] [Related]
33. Stage analysis of pancreatic ductal adenocarcinoma via network analysis. Bahadorimonfared A; Farahani M; Rezaei Tavirani M; Razzaghi Z; Arjmand B; Rezaei M; Nikzamir A; Ehsani Ardakani MJ; Mansouri V Gastroenterol Hepatol Bed Bench; 2024; 17(3):297-3030. PubMed ID: 39308540 [TBL] [Abstract][Full Text] [Related]
34. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
35. Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies. Mogal MR; Jame JA; Sohel M; Mozibullah M; Mahmod MR; Junayed A; Kar N; Arbia L; Al Mamun A; Sikder MA Cancer Rep (Hoboken); 2024 Apr; 7(4):e2059. PubMed ID: 38639039 [TBL] [Abstract][Full Text] [Related]
36. Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis. Yang B; Zhang M; Luo T Front Genet; 2020; 11():517362. PubMed ID: 33193601 [TBL] [Abstract][Full Text] [Related]
37. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration. Wang Y; Zhou D; Kong Y; Yang Q; Ding Y; Wang W Biomed Res Int; 2022; 2022():6109052. PubMed ID: 36582601 [TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of Xu X; Yu Y; Yang L; Wang B; Fan Y; Ruan B; Zhang X; Dai H; Mei W; Jie W; Zheng S Front Pharmacol; 2023; 14():1079539. PubMed ID: 36937875 [No Abstract] [Full Text] [Related]
39. Construction of a circRNA-miRNA-mRNA network to explore the pathogenesis and treatment of pancreatic ductal adenocarcinoma. Xiao Y J Cell Biochem; 2020 Jan; 121(1):394-406. PubMed ID: 31232492 [TBL] [Abstract][Full Text] [Related]
40. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]